SCHEMBL503307

SCHEMBL503307

Oc1nc2ccccc2nc1-c1ccco1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.75
MAPT P10636 7/20 0.75
KMT2A Q03164 7/20 0.75
ALDH1A1 P00352 6/20 0.75
POLB P06746 6/20 0.75
BLM P54132 6/20 0.75
TDP1 Q9NUW8 5/20 0.75
L3MBTL1 Q9Y468 5/20 0.75
KDM4E B2RXH2 5/20 0.75
PTPN7 P35236 5/20 0.75
RECQL P46063 4/20 0.75
HPGD P15428 4/20 0.75
ALOX15 P16050 3/20 0.75
CASP1 P29466 3/20 0.75
CASP7 P55210 3/20 0.75
HSD17B10 Q99714 3/20 0.75
PKM P14618 2/20 0.75
TSHR P16473 2/20 0.75
THRB P10828 3/20 0.55
USP2 O75604 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27734202 0.86 MEN1 (1.00) MEN1MAPTKMT2AALDH1A1POLB
SCHEMBL28079386 0.78 MEN1 (0.81) MEN1MAPTKMT2AALDH1A1POLB
SCHEMBL8006645 0.78 ALDH1A1 (0.75) MEN1MAPTKMT2AALDH1A1POLB
SCHEMBL13787415 0.75 ALDH1A1 (0.70) MEN1MAPTKMT2AALDH1A1POLB
SCHEMBL13836924 0.74 MEN1 (0.62) MEN1MAPTKMT2AALDH1A1POLB
SCHEMBL7696747 0.73 TDP1 (1.00) MEN1MAPTKMT2AALDH1A1POLB
SCHEMBL2114343 0.73 MAPT (1.00) MEN1MAPTKMT2AALDH1A1POLB
SCHEMBL28532446 0.70 TDP1 (0.62) MEN1MAPTKMT2AALDH1A1POLB
SCHEMBL10009826 0.70 ALOX5 (0.49) MEN1MAPTKMT2AALDH1A1TDP1
SCHEMBL3593759 0.70 KMT2A (0.67) MEN1KMT2AALDH1A1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8445678-B2 2-quinoxalinol salen compounds and uses thereof AUBURN UNIVERSITY (US) 2013-05-21 US disclosed
US-20120028362-A1 2-QUINOXALINOL SALEN COMPOUNDS AND USES THEREOF AUBURN UNIVERSITY (US) 2012-02-02 US disclosed
US-20090286968-A1 2-Quinoxalinol Salen Compounds and Uses Thereof AUBURN UNIVERSITY (US) 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286968-A1 2-Quinoxalinol Salen Compounds and Uses Thereof NQO1, NQO2, SQOR MEN1 2806/4885MAPT 3402/4885KMT2A 1142/4885
US-20120028362-A1 2-QUINOXALINOL SALEN COMPOUNDS AND USES THEREOF NQO1, NQO2, SQOR MEN1 2806/4885MAPT 3402/4885KMT2A 1142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.